Matched-Pair Comparison of
18F-DCFPyL
18F-PSMA-1007
PET/CT
PSMA
prostate cancer
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
20
10
2020
accepted:
13
01
2021
pubmed:
7
2
2021
medline:
6
1
2022
entrez:
6
2
2021
Statut:
ppublish
Résumé
Over 20 different prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals for both imaging and therapy have been synthesized. Although variability in biodistribution and affinity for binding to the PSMA receptor is known to exist between different PSMA-targeting radiopharmaceuticals, little is known about the clinical implications of this variability. Therefore, this study analyzed differences in interreader agreement and detection rate between 2 regularly used
Identifiants
pubmed: 33547211
pii: jnumed.120.258574
doi: 10.2967/jnumed.120.258574
doi:
Substances chimiques
Oligopeptides
0
PSMA-1007
0
Niacinamide
25X51I8RD4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1422-1429Informations de copyright
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.